Sarepta CEO: ‘We Have, I Believe, a Very Laudable History of Being Extraordinarily Transparent’

Sarepta Therapeutics knew about the death of a patient treated with its experimental gene therapy for a type of limb-girdle muscular dystrophy, but said nothing public for a month. Financial analysts lambasted Sarepta executives for failing to disclose the fatality when the company announced a restructuring that includes stopping work on this limb-girdle program. The…

Read More

4 Ways to Help Vulnerable Patients Engage with Primary Care

it is essential that more individuals receive high-quality, evidence-based primary care. While government agencies are working towards this objective, significant efforts can also be made at the community level and by independent primary care providers. The post 4 Ways to Help Vulnerable Patients Engage with Primary Care appeared first on MedCity News.

Read More